Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β

JOURNAL OF CLINICAL IMMUNOLOGY

SPRINGER/PLENUM PUBLISHERS

1. Fonds de la recherche en sante du Quebec clinician-scientist scholar Junior 2 program
2. Intramural Research Program of the National Institute of Allergy
3. Infectious Diseases, National Institutes of Health
4. Howard Hughes Medical Institute
5. Rockefeller University
6. St. Giles Foundation
7. National Institutes of Health (NIH) [R01AI088364]
8. National Center for Advancing Translational Sciences (NCATS)
9. NIH Clinical and Translational Science Award (CTSA) program [UL1 TR001866]
10. Fast Grant from Emergent Ventures
11. Mercatus Center at George Mason University
12. Yale Center for Mendelian Genomics
13. GSP Coordinating Center - National Human Genome Research Institute (NHGRI) [UM1HG006504, U24HG008956]
14. Fisher Center for Alzheimer's Research Foundation
15. Meyer Foundation
16. French National Research Agency (ANR) under the Investments for the Future program [ANR-10-IAHU-01]
17. Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence [ANR-10LABX-62-IBEID]
18. French Foundation for Medical Research (FRM) [EQU201903007798]
19. FRM and ANR GENCOVID project [ANRSCOV05]
20. Square Foundation
21. Grandir -Fonds de solidarite pour l'enfance
22. SCOR Corporate Foundation for Science
23. Institut National de la Sante et de la Recherche Medicale (INSERM)
24. University of Paris
25. MD-PhD program of the Imagine Institute
26. Fondation Bettencourt-Schueller
27. Senior Clinical Investigator at the Research Foundation -Flanders
28. CSL Behring Chair of Primary Immunodeficiencies at KU Leuven C1 [C16/18/007]
29. VIB GC PID Grant
30. FWO Grant [G0C8517N, G0B5120N, G0E8420N]
31. Jeffrey Modell Foundation
32. ERN-RITA